替米沙坦联合比索洛尔治疗中青年舒张期高血压的疗效观察(3)
![]() |
第1页 |
参见附件。
[6] Karaye K M.Relationship between Tei index and left ventrieu largeometric patterns in a hypertensive population:a cross-sectional study[J].Cardiovasc Uhrasound,2011,9(1):21.
[7] Vesely D L.Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure,renal failure and cancer[J].Clin Exp Pharmacol Physiol,2009,33(3):169-171.
[8] Shimizu Y,Yamasaki F,Furuno T,et al.Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension[J].Int J Gen Med,2012,5(2):753-758.
[9]倪锦辉.比索洛尔干预治疗高血压慢性心力衰竭左心室重构的研究[J].中国医学创新,2013,10(16):30-31.
[10] Cruickshank J M.Are we misunderstanding beta-blockers[J].Int J Cardiol,2007,120(1):10-27.
[11]余天浩,李瑜辉,陈武奇.厄贝沙坦与富马酸比索洛尔联合用药治疗中青年单纯舒张期高血压168例[J].Guide of China Medicine,2012,10(18):414-416.
[12]李永红,陈晓宁.替米沙坦与倍他乐克治疗中青年舒张型高血压的临床效果分析[J].吉林医学,2012,33(23):5013.
[13]包敦仁.厄贝沙坦与美托洛尔的联合治疗高血压对患者性功能的影响[J].中外医疗,2013,13(11):110.
(收稿日期:2013-12-14) (编辑:程旭然)
您现在查看是摘要介绍页,详见PDF附件。